Genome Editing of Veterinary Relevant Mycoplasmas Using a CRISPR-Cas Base Editor System

被引:10
|
作者
Ipoutcha, Thomas [1 ]
Rideau, Fabien [1 ]
Gourgues, Geraldine [1 ]
Arfi, Yonathan [1 ]
Lartigue, Carole [1 ]
Blanchard, Alain [1 ]
Sirand-Pugnet, Pascal [1 ]
机构
[1] Univ Bordeaux, UMR BFP, INRAE, Villenave Dornon, France
关键词
CRISPR-Cas9; mycoplasma; animal pathogens; minimal cell; genome editing; TARGETED HOMOLOGOUS RECOMBINATION; SPIROPLASMA-CITRI; TRANSPOSON MUTAGENESIS; GENE DISRUPTION; ORIC PLASMIDS; GALLISEPTICUM; DNA; PATHOGENICITY; IDENTIFICATION; CYTADHERENCE;
D O I
10.1128/aem.00996-22
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mycoplasmas are minimal pathogenic bacteria that infect a wide range of hosts, including humans, livestock, and wild animals. Major pathogenic species cause acute to chronic infections involving still poorly characterized virulence factors. Mycoplasmas are minimal bacteria that infect humans, wildlife, and most economically relevant livestock species. Mycoplasma infections cause a large range of chronic inflammatory diseases, eventually leading to death in some animals. Due to the lack of efficient recombination and genome engineering tools for most species, the production of mutant strains for the identification of virulence factors and the development of improved vaccine strains is limited. Here, we demonstrate the adaptation of an efficient Cas9-Base Editor system to introduce targeted mutations into three major pathogenic species that span the phylogenetic diversity of these bacteria: the avian pathogen Mycoplasma gallisepticum and the two most important bovine mycoplasmas, Mycoplasma bovis and Mycoplasma mycoides subsp. mycoides. As a proof of concept, we successfully used an inducible SpdCas9-pmcDA1 cytosine deaminase system to disrupt several major virulence factors in these pathogens. Various induction times and inducer concentrations were evaluated to optimize editing efficiency. The optimized system was powerful enough to disrupt 54 of 55 insertion sequence transposases in a single experiment. Whole-genome sequencing of the edited strains showed that off-target mutations were limited, suggesting that most variations detected in the edited genomes are Cas9-independent. This effective, rapid, and easy-to-use genetic tool opens a new avenue for the study of these important animal pathogens and likely the entire class Mollicutes. IMPORTANCE Mycoplasmas are minimal pathogenic bacteria that infect a wide range of hosts, including humans, livestock, and wild animals. Major pathogenic species cause acute to chronic infections involving still poorly characterized virulence factors. The lack of precise genome editing tools has hampered functional studies of many species, leaving multiple questions about the molecular basis of their pathogenicity unanswered. Here, we demonstrate the adaptation of a CRISPR-derived base editor for three major pathogenic species: Mycoplasma gallisepticum, Mycoplasma bovis, and Mycoplasma mycoides subsp. mycoides. Several virulence factors were successfully targeted, and we were able to edit up to 54 target sites in a single step. The availability of this efficient and easy-to-use genetic tool will greatly facilitate functional studies of these economically important bacteria.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Orthogonal CRISPR-Cas tools for genome editing, inhibition, and CRISPR recording in zebrafish embryos
    Takasugi, Paige R.
    Wang, Shengzhou
    Truong, Kimberly T.
    Drage, Evan P.
    Kanishka, Sahar N.
    Higbee, Marissa A.
    Bamidele, Nathan
    Ojelabi, Ogooluwa
    Sontheimer, Erik J.
    Gagnon, James A.
    GENETICS, 2022, 220 (01)
  • [42] Occurrence and Nature of Off-Target Modifications by CRISPR-Cas Genome Editing in Plants
    Sturme, Mark H. J.
    van der Berg, Jan Pieter
    Bouwman, Lianne M. S.
    De Schrijver, Adinda
    de Maagd, Ruud A.
    Kleter, Gijs A.
    Battaglia-de Wilde, Evy
    ACS AGRICULTURAL SCIENCE & TECHNOLOGY, 2022, 2 (02): : 192 - 201
  • [43] Genome Editing of Babesia bovis Using the CRISPR/Cas9 System
    Hakimi, Hassan
    Ishizaki, Takahiro
    Kegawa, Yuto
    Kaneko, Osamu
    Kawazu, Shin-ichiro
    Asada, Masahito
    MSPHERE, 2019, 4 (03):
  • [44] Genome editing of immune cells using CRISPR/Cas9
    Kim, Segi
    Hupperetz, Cedric
    Lim, Seongjoon
    Kim, Chan Hyuk
    BMB REPORTS, 2021, 54 (01) : 59 - 69
  • [45] Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing
    Chadwick, Alexandra C.
    Musunuru, Kiran
    CURRENT ATHEROSCLEROSIS REPORTS, 2017, 19 (07)
  • [46] Efficient Genome Editing in Setaria italica Using CRISPR/Cas9 and Base Editors
    Liang, Zhen
    Wu, Yuqing
    Ma, Lingling
    Guo, Yingjie
    Ran, Yidong
    FRONTIERS IN PLANT SCIENCE, 2022, 12
  • [47] CRISPR/Cas system: A game changing genome editing technology, to treat human genetic diseases
    Hussain, Wajid
    Mahmood, Tariq
    Hussain, Jawad
    Ali, Niyaz
    Shah, Tariq
    Qayyum, Sadia
    Khan, Ibrar
    GENE, 2019, 685 : 70 - 75
  • [48] Advances in CRISPR-Cas based genome engineering
    Katrekar, Dhruva
    Hu, Michael
    Mali, Prashant
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2017, 1 : 78 - 86
  • [49] CRISPR-Cas system: a powerful tool for genome engineering
    Liu, Liang
    Fan, Xiu-Duo
    PLANT MOLECULAR BIOLOGY, 2014, 85 (03) : 209 - 218
  • [50] The CRISPR/Cas9 system and its applications in crop genome editing
    Bao, Aili
    Burritt, David J.
    Chen, Haifeng
    Zhou, Xinan
    Cao, Dong
    Lam-Son Phan Tran
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2019, 39 (03) : 321 - 336